{"title":"Kawasaki disease is not linked to COVID-19 in Chinese pediatric population","authors":"Fang Liu, Li-Ping Xie, Yin Wang, Wei-Li Yan, Guo-Ying Huang","doi":"10.21037/PM-20-112","DOIUrl":null,"url":null,"abstract":"Increasing cases of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presenting with severe Kawasaki-like disease have recently been reported in some Western countries, raising the possibility of SARS-CoV-2 being a trigger of Kawasaki disease (KD). We aimed to investigate whether KD is linked to coronavirus disease 2019 (COVID-19) in Chinese pediatric population. Methods: Patients were enrolled if diagnosed with KD in the 40 hospitals of China Kawasaki Disease Research Collaborative Group from January to April 2020, the COVID-19 epidemic period in China. Information of demographic data, KD shock syndrome, macrophage activation syndrome (MAS), evidence of SARS-CoV-2 infection and the number of KD cases were retrospectively analyzed. Results: The completed response was received from 29/40 hospitals (72.5%) across 19 provinces. Of 2,108 KD patients enrolled, the median age was 1.9 years and 63.8% were male. KD shock syndrome and MAS were diagnosed in 8 (0.4%) and 2 (0.1%) patients, respectively, none of whom had contact history with COVID-19 patients. A greater number of KD cases from January to April 2020 than the upper limit of 95% confidence interval (95% CI) of estimated numbers of cases of the past 3 years were observed in only 2 out of 29 (6.9%) hospitals. Reverse transcription-polymerase chain reaction (RT-PCR) tests in 434 patients and antibody tests in 64 patients for SARS-CoV-2 were all negative, including nine with exposure history. Conclusions: There is no evidence of the link of KD with COVID-19 in Chinese children in terms of its prevalence and severity. © Pediatric Medicine. All rights reserved.","PeriodicalId":74411,"journal":{"name":"Pediatric medicine (Hong Kong, China)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric medicine (Hong Kong, China)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/PM-20-112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
中国儿科人群川崎病与COVID-19无关联
最近,一些西方国家报告了越来越多的儿童感染严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)并出现严重川崎样疾病的病例,这增加了SARS-CoV-2引发川崎病(KD)的可能性。我们的目的是调查KD是否与中国儿科人群的冠状病毒病2019 (COVID-19)有关。方法:选取2020年1 - 4月中国新冠肺炎流行期中国川崎病研究协进组所属40家医院诊断为KD的患者。回顾性分析人口学资料、KD休克综合征、巨噬细胞激活综合征(MAS)、SARS-CoV-2感染证据及KD病例数。结果:19个省40家医院中有29家(72.5%)收到了完整的回复。纳入的2108例KD患者中位年龄为1.9岁,63.8%为男性。KD休克综合征8例(0.4%),MAS 2例(0.1%),均无与COVID-19患者接触史。2020年1月至4月,29家医院中只有2家(6.9%)的KD病例数高于过去3年估计病例数的95%置信区间(95% CI)上限。434例患者逆转录聚合酶链反应(RT-PCR)阴性,64例患者抗体检测阴性,其中9例有暴露史。结论:在中国儿童中,没有证据表明KD与COVID-19的患病率和严重程度有关。©儿科医学。版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。